About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Philadelphia | 53 Studies

Clinical Trials LupusPhiladelphia

Lupus Clinical Trials in Philadelphia

Find 53 clinical trials for lupus near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Lupus trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-53 of 53 trials

CompletedA Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisThe purpose of this study is to evaluate the safety and tolerability of escalating, multiple subcutaneous (SC) doses of VIB7734 in participants with Systemic Lupus Erythematosus…NCT03817424·Anniston, Alabama and 29 others Active not recruitingCARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101The purpose of this study is to assess the safety, tolerability, and clinical activity of KYV 101 (a fully-human anti-CD19 CAR T-cell therapy) in adult subjects with B cell-driven…NCT06152172·Philadelphia, Pennsylvania

Lupus Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusNCT06121297·Orange, California and 22 others

CompletedHigh-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideThis study compares the effectiveness of high-dose cyclophosphamide treatment with the "gold standard" treatment, monthly intravenous (IV) cyclophosphamide, in people with…NCT00005778·Baltimore, Maryland and 2 others

CompletedA Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusThis is a Phase II/III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of rituximab compared with placebo when combined with a…NCT00137969·Birmingham, Alabama and 64 others

CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusThe primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)NCT01408576·Birmingham, Alabama and 227 others

RecruitingAn Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsA Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus…NCT05835310·Phoenix, Arizona and 102 others

CompletedSafety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the safety and efficacy of 3 different doses of belimumab, administered in addition to standard therapy, in patients with active SLE…NCT00071487·Birmingham, Alabama and 61 others

CompletedSafety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistryThe purpose of this prospective, observational cohort study is to evaluate the incidence of adverse events of special interest (AESI) and effectiveness in participants with…NCT01729455·Birmingham, Alabama and 178 others

CompletedJBT-101 in Systemic Lupus Erythematosus (SLE)The objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE).NCT03093402·La Jolla, California and 15 others

CompletedA Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)This study evaluates the impact of 13 bi-weekly intravenous infusions of RSLV-132 on the cutaneous manifestations in subjects with systemic lupus erythematosus.NCT02660944·El Cajon, California and 15 others

RecruitingA Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus NephritisThis Phase IIa, open-label, single-arm study includes an initial Safety Run-In followed by dose expansion to evaluate the safety, tolerability, cellular kinetics…NCT07328581·Chicago, Illinois and 3 others

TerminatedSafety of Estrogens in Lupus: Hormone Replacement TherapySafety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can…NCT00000419·Birmingham, Alabama and 15 others

PreviousPage 3 of 3

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia